From March 14th- October 18th, this year’s annual conference of DGHO, OeGHO, SGMO and SGH took place in Stuttgart. GermanOncology has presented the following posters:

Comparison of therapy behaviour in 2015 and 2012 with patients exhibiting chronic lymphocytic leukaemia (B-CLL) based on real-world-evidence data from oncological practises in Germany

Cost analysis in patients with relapsed or refractory multiple myeloma (MM) based on Real-World-Evidence data from oncological practises in Germany

Molecular analysis and subsequent therapy decisions when molecular markers are known in patients with metastatic colorectal carcinoma under real care conditions in oncology practices – first results of the GO-KOLORAS registry study